Introduction
The protozoan parasite Toxoplasma gondii, an obligate intracellular eukaryotic pathogen of the phylum Apicomplexa, may cause toxoplasmosis in many warmblooded animals, including humans. 1 Transplacental passage of the parasite causes congenital toxoplasmosis. Transmission frequency and severity of disease vary with gestation time: during the first weeks, vertical transmission is of low rate, although if it occurs, it causes major damage to the embryo. The transmission frequency increases to near 80% by the end of pregnancy, but the proportion of ill newborns is low. 2 The changes in endocrine phenomena occurring during pregnancy, as well as the size and maturity of the placenta and of the embryonic/fetal immune response certainly affect the ability to be protected from invasion or to fight infection. [3] [4] [5] The size of the inoculum is also relevant for congenital infection risk and disease severity. Besides, the genetic background of the mother and the product is likely to influence outcome. Recent investigations have shown surprising phenomena; that is, molecules and cells that protect the mother might favor vertical transmission. 6, 7 Few direct data are available, but indirect evidence points to several candidate polymorphic host immune response genes that may influence fetal infection or clinical outcome of the product.
Immune response in acquired toxoplasmosis
The key immune system molecules and cells related to control acquired (noncongenital) toxoplasmosis have been studied extensively. It can be summarily said that professional phagocytes and natural killer (NK) cells are main effectors during the innate phase. Human Toll-like receptors (TLRs) of importance are TLR2 and TLR4. Their ligands induce the production of inflammatory chemokines and cytokines (that is, CCL3, CCL5, interleukin (IL)-6, IL-8 and IL-12) that mediate recruitment of professional phagocytes and dendritic cells. [8] [9] [10] Crucial adaptative responses include CD8 þ cytotoxicity of infected cells, antibody-mediated phagocytosis and NK cell antibody-mediated cytotoxicity (NK-ADCC). A T helper 1 (Th1) profile (that is, IL-12 and interferon-g (IFN-g)) is essential to induce these mechanisms. 11 Th17 cells are also involved in acute polymorphonuclearmediated resistance to Toxoplasma.
12 Some chemokines and their receptors have a determinant role for NK and dendritic cell recruitment; in addition, polarization to a Th1 profile depends on CCR5 stimulation by T. gondii cyclophilin 18, CCL3, CCL4 or CCL5. 13, 14 Other CCRs, such as CCR1, CCR2 and CXCR2, have important roles in neutrophil proliferation and monocyte recruitment, which are essential for parasite control. [15] [16] [17] [18] An early Th2 phenotype (driven by IL-4) is associated with bad outcome. 19, 20 Antibodies and their Fc receptors (FcRs) have important roles as well. 21, 22 Antibodies of the immunoglobulin (Ig)A, IgM and IgG1 (equivalent to murine IgG2a) classes protect through neutralization, complement activation, opsonization of phagocytes or NK-ADCC. IgG2 and IgG4 are poor complement fixative subclasses and of low affinity for FcRs, and thus they are not expected to relate to protection. Similarly, IgE antibodies are related to lymphadenopathy in the acute phase. 22 Once the parasite encysts, the Th1/Th17 responsedriven inflammatory reactions are downregulated, avoiding inflammatory damage. This is mediated by IL-10, transforming growth factor-b (TGF-b) and IL-27.
11,23,24
Immune response and pregnancy There is some parallelism between the response that controls T. gondii infection and that related to pregnancy success. During implantation, a Th1-type inflammatory environment is essential for invasion of the endometrium by trophoblasts; it is also necessary during the first month of pregnancy to favor spiral arteries growth and protection from infection. 25, 26 Implantation is induced by IFN-g, which activates NK cells and regulates colony stimulation factors, promoting trophoblast growth. Chemokine and chemokine receptor signaling processes mediate leukocyte recruitment and controlled trophoblast invasion and thus implantation and placentation.
27 CCR1 is present on invading human trophoblasts and promotes their migration. Its ligand, CCL14, is expressed in endometrial vasculature, as well as in epithelial and decidual cells during early pregnancy. CCR2 and CCL2 are coexpressed by human first-trimester decidual tissue and the latter is upregulated by pregnancy-associated hormones, such as estrogen, progesterone and human chorionic gonadotrophin. 28 CCL5 promotes a Th1 profile and an adequate proimplantatory microenvironment, influencing trophoblast cell survival and balance of maternal T regulatory/T effector lymphocytes in favor of maternal tolerance.
29
CXCL12/CXCR4 crosslinking stimulates antiapoptotic pathways in cultured trophoblasts, suggesting that they are important in trophoblast survival. 30 CX3CR1 is present on invading human trophoblasts and promotes their migration by action of its ligand CX3CL1, which is expressed by endometrial vasculature, epithelial and decidual cells during early pregnancy. 31 This early inflammation is downregulated, and hence the invading trophoblasts do not overgrow and destroy the supporting decidual/endometrial tissues. IL-10 promotes implantation and development of the fetus. It also influences human leukocyte antigen (HLA) class I expression at the feto-maternal barrier, which protects the fetus from rejection. TGF-b is the major inhibitor of cytotrophoblast outgrowth, fusion and syncytialization. It inhibits the production of human chorionic gonadotrophin, human placental lactogen, progesterone and oestradiol. [32] [33] [34] [35] During most of the gestation period, a delicate balance of the Th1/Th2/regulatory T cell cytokines prevails to promote fetal growth and to inhibit allorejection by maternal immune response. By the end of pregnancy, a Th1 inflammatory response arises again, promoting rupture of membranes, placental detachment and partum. 4, 36 Candidate immune genes with a role in T. gondii vertical transmission or fetal pathology HLA. The major histocompatibility complex (MHC) antigens have an important role in acquired toxoplasmosis for both CD8 þ lymphocyte-mediated cytolysis and for CD4 þ -mediated regulation of the immune response. Many studies using the murine model have described the role of these antigens in the control of parasite replication or generation of inflammatory disease. 11 Thus, MHC antigens are thought to have a major role in fetus susceptibility to develop clinical problems. In this regard, Mack et al. 37 showed that among congenitally infected Caucasian children, the DQ3 allele frequency was significantly higher in infants with hydrocephalus than in those without it. In transgenic chimerical mice they also showed that the human DQ3 allele protected less than the DQ1 against brain necrosis.
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Immunohistochemically, HLA-G and a small amount of HLA-C are the only molecules that can be detected in extravillous chorionic cytotrophoblasts. 25 Its low polymorphism ensures that paternal HLA-G expressed in the trophoblast does not induce a maternal alloresponse by the class I MHC-restricted CD8 þ cells. Conversely, activation of NK cells depends on the lack of MHC expression in the target cells, but extravillous cytotrophoblast HLA-G expression induces IL-10 and other cytokines, which build a favorable milieu for pregnancy maintenance. 38 Thus, the trophoblast resists NK cell and CD8 þ lysis by disturbed antigen recognition through HLA-G, although low diversity peptides are presented by HLA-G to cytotoxic T lymphocytes. 38 Nothing is known about T. gondii antigen presentation through HLA-G, but it would induce limited CD8 þ lysis of infected cells and Th1-type inflammation during early pregnancy, which would partially favor local parasite control and implantation success.
Cytokines, chemokines, adhesion molecules and receptors As IFN-g and related cytokines and chemokines are key molecules for protection against acquired toxoplasmosis and successful implantation of the embryo, a positive relation between inflammation degree and protection from T. gondii vertical transmission would be expected. 36, 39, 40 In fact, the inflammatory cells recruited by Th1 profile-associated chemokines and cytokines protects the embryo from infections. 4, 26 Nevertheless, recent data on the effect of IFN-g on congenital toxoplasmosis in mouse models indicate that extremely high levels may induce resorption of the embryo without actual infection of the placenta. 41 This implies that sterile abortion may be induced indirectly by T. gondii in mothers with strong Th1 or low IL-10/TGF-b/IL-27 responses. Polymorphisms related to strong Th1 inflammatory response would hypothetically cause this clinical situation, similar to the IFN-g gene promoter mutation T-179G, which causes a 6-to 13-fold higher expression by T cells (Table 1) . 42, 43 Direct invasion of placental cells by T. gondii is regulated by immune response molecules. Barbosa et al. 44 showed that BeWo line trophoblasts are susceptible to invasion and replication, especially if they are Table 1 Human immune response genes: hypothetical effect of some polymorphisms on congenital toxoplasmosis Table 1) . 32, 35, [45] [46] [47] It is important to emphasize that BeWo cells are not models for the syncytiotrophoblast, the main mother/conceptus interface. Thus, these results would be related to local invasion of the placenta, but not necessarily to passage across the mother/embryo barriers.
A paradoxical phenomenon has been observed in animal and in vitro models; that is, IFN-g may support vertical transmission at the time it protects the mother from parasite-induced damage. 6, 48 Treatment of human placenta villous explants with soluble antigen from T. gondii plus IFN-g significantly induces parasitized white blood cell adhesion to placental villous cells, augmenting in this way vertical transmission probability. 49, 50 Pretreatment of syncytiotrophoblast with the inflammatory cytokines IFN-g, tumor necrosis factor-a (TNF-a) and IL-1a increases the number of monocytes bound to the surface by upregulation of intercellular adhesion molecule 1 (ICAM-1). 49, 50 An interesting finding indicates that the parasite may directly adhere to the syncytiotrophoblast through the adhesin called microneme 2 (MIC2), which binds to human ICAM-1. 51 Another molecule implicated in this phenomenon is macrophage migration inhibitory factor (MIF), which is produced by first-trimester placental trophoblasts, decidua and cytotrophoblasts, and is implicated in angiogenesis, cell proliferation, and thus in implantation and early embryonic development. 52 Intravillous cytotrophoblasts produce MIF in response to T. gondii soluble extract; and then, ICAM-1 is induced in the syncytiotrophoblast maternal face. [53] [54] [55] Hypothetically, the maternal À179T low-expression allele of IFN-g, as well as the fetal Kilifi allele of ICAM-1 or the low-expression haplotype of MIF, would be compatible with resistance against vertical transmission (Table 1) . 43, [56] [57] [58] TNF-a is a key cytokine in acquired toxoplasmosis control. It is mainly produced by macrophages and mediates phagocytosis enhancing and damage to infected cells. 59 At the mother/embryo interface, it is expressed by maternal decidual macrophages, in which it regulates fetal trophoblast growth and invasion. Abnormal levels are associated with amniotic infections, recurrent spontaneous abortions, preeclampsia, preterm labor and endometriosis. Several single-nucleotide polymorphisms are known for TNF-a. Polymorphism -308A has been related to TNF-a overexpression (Table 1) . 60 After a maternal infection it could have two effects: high levels would overinduce implantation, thereby inducing sterile embryonic loss, but in low-expression allele carrier mothers, it could be ineffective to control infection, allowing parasite vertical transmission or destruction of the early placenta. Several polymorphisms have been described in genes of chemokines, TLRs or regulatory cytokines, such as IL-4, TGF-b, IL-10 or their receptors, that might cause differences among mother/newborn pairs during T. gondii acute infection. They affect susceptibility or resistance to several infectious diseases. 45, 46, [61] [62] [63] [64] In addition, chemokine receptor signaling processes are important for leukocyte recruitment and controlled trophoblast invasion and thus for implantation and placentation. 25, 26 CCR2 and CCR5 are chemokine receptors that have been assigned a function in toxoplasmosis and, independently in pregnancy, they protect from uncontrolled T. gondii replication in adults and favor trophoblast survival or invasion (related to a Th1 response), partially explaining the first-trimester resistance against vertical transmission. 11, 13, 14, [25] [26] [27] The 64I allele of CCR2 and the D32 deletion of CCR5 negatively influence expression of the products, which have shown implications in noninfectious diseases and, of special interest, human immunodeficiency virus congenital transmission. [65] [66] [67] Similarly, CCL5 (RANTES) production in response to Brucella abortus correlated with IFN-g induction and contributed to abortion in mice. 68 Two polymorphisms of CCL5 in either the mother or the product would have opposite effects on congenital toxoplasmosis occurrence or pathology: the À28 C/G or G/G would be protective against infection, but without proper control it could relate to sterile abortion. 69 On the contrary, carriers of the À403A allele would have low CCL5 levels and thus people with this allele would have higher risk of vertical transmission. 70 The recognition of T. gondii pathogen-associated molecular patterns is mediated by TLR2, TLR4 whose signaling cascades are implicated in eliciting IL-12 and TNF-a. TLR2 specifically recognizes glycosylphosphatidylinositol of the tachyzoites.
9,11,71,72 TLR2 and TLR4 are expressed on the surface of the syncytiotrophoblast that recognizes microbes and produces TNF-a, IL-6 and IL-8. 73, 74 Intrauterine infections may result in either trophoblast apoptosis or cytokine production that signal immune cells and promote trophoblast survival and destruction of infectious agents. A polymorphism in the TLR2 gene 16934A is linked to diminished synthesis of TNF-a and IFN-g. This potentially leads to aberrant innate immune responses, which may contribute to early preterm birth. 75 Individuals possessing the TLR4 co-segregating polymorphisms, Asp299Gly and Thr399Ile, are hyporesponsive to lipopolysacharide and are more susceptible to Gram-negative bacterial infections. 73, 76, 77 Those fetuses carrying the low-expression alleles of these receptors would hypothetically be more susceptible to die either by uncontrolled parasite replication/invasion or impaired trophoblast growth.
Regulation of most Th1 effects is mainly mediated by IL-10 and TGF-b. In vitro, the haplotype À1082G/ À819C/À592C of the IL-10 gene is associated with an increase in the protein amount. Among reported singlenucleotide polymorphisms of TGF-b gene, the Arg25 is also related with an increased expression. 35, 45, 46 Highexpression polymorphisms of either TGF-b or IL-10 would protect the implanting embryo against sterile abortion or IFN-g/ICAM-1-facilitated vertical transmission, but would be negative for parasite-induced pathogenesis control in the conceptus already infected by T. gondii. The classical Th2 interleukin, IL-4, has been shown to be nonprotective in T. gondii-acquired infection in both humans and animals. 19, 20 It stimulates cellular mechanisms not protective against intracellular parasites, and even induces undesirable effects, similar to IgE antibodies or Th2 inflammation. It is produced by cytotrophoblasts, decidual macrophages and both maternal and fetal endothelial cells (Table 1) . 78 Polymorphism À590TT of this gene is related with asthma and atopy because of high expression. 79 It may contribute to class II MHC molecule upregulation on both maternal and fetal macrophages, activating antigen-presenting cells involved in antimicrobial response during pregnancy.
The proinflammatory IL-6 is produced by trophoblasts, maternal decidua and chorionic villous of the placenta. It induces human chorionic gonadotrophin liberation by trophoblasts, promotes progesterone and Th2 cytokines production, for example, IL-4, and suppresses Th1 response, and is associated with neonatal sepsis inflammation. 80 The -174G allele correlates with high expression levels of the protein. 81 As for other cytokines/chemokines, the effect of polymorphisms related to increased expression of IL-6 on T. gondii vertical transmission must be considered in terms of the time of pregnancy at the moment of infection, and on its possible dual role; for example, a strong IL-6 response would recruit inflammatory cells (phagocytes for example) that may fight the parasite, but they would counteract IFN-g action.
Igs and FcRs polymorphisms
Igs and their receptors are crucial against microbial agents. 21 In addition, the four IgG subclasses are actively transported across syncytiotrophoblast and the villous fetal endothelial cells, and hence they reach the conceptus blood and protect him/her even for several months after birth. 82 Besides, Igs are produced by the human fetus by week 14 of gestation and they may be stimulated by antigens. 83, 84 Four systems have been described for the constant heavy and k light chain genes of Igs, Gm, Am, Em and Km, with 24 allotypes. 85, 86 Gm and Km allotypes are associated with amino acid substitutions in the constant regions-the former influencing IgG1, IgG2 and IgG3 subclass levels-and are inherited in the Mendelian manner. 87 The sizable gene family of human FcRs belongs to the large Ig supergene family. Their products show a wide cellular distribution, and through interaction with Igs, mediate a variety of leukocyte functions. 88 Evidence from the rodent toxoplasmosis models and functional correspondence of humans Igs and FcRs to those of mice suggest that fetal alleles associated with high serum levels of Igs, or with strong Ig/FcR binding would be related to better clinical outcome in the fetus, although they could also be related to an exacerbated, that is, damaging response. 22 Some polymorphisms of the human Fc receptors and their hypothetical effects are listed in Table 2 . Eight genes transcribed in different mRNAs have been recognized. The FcgRII a, b and c genes encode highly homologous proteins regarding the extracellular parts, but show strong structural divergence in cytoplasmic domains. Differences in the subclass specificity between the forms and differential expression on distinct cells have critical consequences for antibody effector functions (Table 2) . 21 Two alleles for each FcgRIa and FcgRIIa (Arg92Ter and His131Arg, respectively) have been described. In the first case, expression is altered, whereas FcgRIIa-His131 binds IgG2 strongly and is considered a heritable risk factor for infectious diseases. [89] [90] [91] In both cases, phagocytosis is compromised. The FcgRIIIa presents a triallelic change: 48Arg and 48His present stronger binding for human IgG1, IgG3 and IgG4, than 48Leu. 92 The FcgRIIIb has a biallelic polymorphism, neutrophil antigen 1 (NA1) or 2 (NA2), expressed in polymorphonuclear neutrophils, which are different in four amino acids. 93 Homozygous NA1 individuals have higher IgG-mediated phagocytosis than NA2. 91, 93 Fc receptors such as FcgRI, FcgRII, FcgRIII and FcRn show heterogeneous expression patterns in the placenta (Table 2) . Immunohistochemical analyses reveal the presence of FcgRI in Hofbauer cells (macrophages) in stromal tissue within the villous; in peripheral monocytes, it mediates endocytosis and degradation of immune complexes, and thus this is probably its function in Hofbauer cells. 94 FcgRII, which binds IgG complexes, has been found in Hofbauer cells and fetal blood endothelium. Transcripts from FcgRIIa or FcgRIIc are present in placenta throughout pregnancy. FcgRIIb mRNA is detected only after week 20 and its expression by endothelial cells of the human placenta may be of particular immunological importance. 94 As this receptor possesses significant affinity for multivalent or aggregated IgG only, it is not yet clear whether endothelial cells are responsible for clearing immune complexes from the fetal circulation or this receptor is mediating transport from the connective stromal tissue to the fetal circulation. 95 Existing data suggest that FcgRIIIb is present in first trimester syncytiotrophoblast. The FcgRIII in Hofbauer cells is expected to be FcgRIIIa, which is detected in macrophages. Both FcgRIIIa and FcgRIIIb bind IgGl and IgG3 complexes, but not IgG2 or IgG4. 82, 94 Transplacental transport of maternal IgG has classically been considered protective for the newborn against infection, and most of the IgG is transferred during the third trimester (Figure 1) . 82 Thus, it would be reasonable that vertical transmission was lower by the end of gestation. Nevertheless, it is just the opposite (Figure 2 ). 2 The FcRn is present in the syncytiotrophoblast and fetal endothelial cells, and binds IgG of the four subclasses with high affinity. 82, 94 It mediates IgG transcytosis and immune complexes during pregnancy. 82, 88, 95 A variable number of tandem repeats (VNTR) region within the promoter, with five different alleles (VNTR1-VNTR5), has been studied in monocytes; this polymorphism influences FcRn expression leading to variable cellular IgG-binding activity. VNTR3 homozygous monocytes express 1.66-fold more FcRn transcript than VNTR2/ VNTR3 heterozygous cells, and hence the latter show diminished IgG binding. 96 There is a remarkable paradox: pregnant women are equally susceptible to T. gondii primo-infection throughout pregnancy, but the parasite is more frequently transmitted after the first trimester. Moreover, the responses that protect the mother from damage favor vertical transmission: IgG1 antibodies were statistically more frequent among mothers whose newborns presented clinical signs when compared with those with newborns infected but asymptomatic. 7 The hypothesis is that FcRn is facilitating rather than protecting from vertical transmission. In this regard, it has been found that maternal antibodies against cytomegalovirus may favor fetal infection. 97 FcRn could be facilitating the 'opsonized' tachyzoite traverse the placenta. 98 The two alleles have significantly different FcaRI-mediated intracellular calcium mobilization and degranulation and cytokine production (IL-6 and TNF-a). In addition, IgA may inhibit IL-6 production by neutrophils from human donors carrying the Ser248 allele. Thus, a-chain alleles of FcaRI affect receptor-mediated signaling and have an important role in immune responses modulation in inflammatory diseases. 98 FceRI regulates the concentration of circulating IgE antibodies; among its genetic variants, the C/T transition at À315 in the promoter of the a-chain gene is related to increased IgE levels. 99 Polymorphisms in these FcaRI and FceRI will probably affect the ability of the already-infected embryo/fetus to respond properly to T. gondii, but little can be suspected about their role in vertical transmission, as they are not present in the syncytiotrophoblast.
Similar to acquired toxoplasmosis, most antibody classes are expected to protect the fetus against cell invasion by neutralizing, mediating killing of the parasite by complement fixation or enhancing cellular defense mechanisms, especially FcgR-mediated NK-ADCC or macrophage/neutrophil phagocytosis. Only IgE is commonly related to bad clinical prognosis, and IgG4 could have either negative or no influence. 7, 22, 100, 101 The few studies on the role of anti-T. gondii antibodies on congenital infections indicate that fetuses or newborns who produce specific IgG2, IgG4 or IgE have bad clinical prognosis.
7,22,100,101
Non-immune response genes Many non-immune genes of the host may influence tissue pathology during embryogenesis. Two molecules were specifically studied by Jamieson et al 102 : the IIB isoform of collagen 2A1, involved in optic nerve conduction during early development, and the ABCA4 form of the retina-specific ATP-binding cassette transporter protein, present in the choroid plexus and at the rim of the photoreceptor outer membrane. 102 They were selected because of their relation to other noninfectious ocular and brain diseases. Studying large European and North American cohorts, they found that certain singlenucleotide polymorphism alleles were associated with ocular problems in the infected newborns, compared with infected but not affected children. Interestingly, they also found epigenetic factors affecting disease outcome.
Concluding remarks
Congenital toxoplasmosis is a very complex phenomenon; the outcome depends of the genetics of three beings: the mother, the conceptus and the parasite. In addition, there are two different phenomena remarkably dependent on the time of gestation at challenge: the probability of vertical transmission at the moment of maternal infection and the pathological effect on the embryo/ fetus (Figure 2 ). Few conclusive results can be gathered from the literature regarding these questions, although candidate genes for further study were identified. The immune response of the developing baby has a crucial role in tissue destruction avoidance. In this regard, lessons from acquired toxoplasmosis explain the negative correlation between the time of congenital infection and the magnitude of clinical problems. These components of the immune response mature through gestation and, therefore, the conceptus is more capable of protecting him (her)self from the parasite later in pregnancy. Genetic polymorphisms related to an early Th1 response (for example, CCR2, CCR5, IL-12 or IFN-g) followed by proper regulation products (for example, IL-10 or TGF-b) are very important. Nevertheless, polymorphisms of immune response genes and pathology in the newborns have not been specifically studied. As mentioned, one HLA marker for hydrocephalus and two 'non-immune' genes in relation to ocular disease have been shown. It is important to emphasize that infection time is crucial even for determining the effect of certain polymorphisms of the mother or the baby on congenital infection. A polymorphism related to strong Th1 response, followed by 'proper' regulatory T cell cytokine synthesis, would have a different effect during implantation and after mid gestation. A relatively clear phenomenon is the effect of an uncontrolled Th1 immune response upon sterile abortion or fetal resorption; this can be occurring in strong responders or enhanced by the parasite (virulent strains induce robust Th1 response). Indirect data have suggested a role of molecules that may facilitate parasite traversing, such as IFN-g, MIF or ICAM-1, and at later stages of pregnancy, the maternal IgG antibodies and the FcRn. The polymorphisms of these genes would be influencing vertical transmission. Thus, the balance between parasite virulence and host Th1 and regulatory T cell gene expressions is fundamental.
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